Prelude Capital Management, LLC Ligand Pharmaceuticals Inc Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $26,061 - $36,875	-291 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $2,662 - $4,822	39 Added 15.48%	291 $33,000
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $11,976 - $20,389	-189 Reduced 42.86%	252 $18,000
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $42,750 - $50,093	441 New	441 $46,000
Q4 2018 Feb 14, 2019	SELL	$128.36 - $272.13 $7,188 - $15,239	-56 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $11,826 - $15,371	56 New	56 $15,000

257

17.9M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.